Zobrazeno 1 - 10
of 147
pro vyhledávání: '"Tsutomu, Saji"'
Autor:
Taichi Kato, Masaru Miura, Tohru Kobayashi, Tetsuji Kaneko, Naoya Fukushima, Kenji Suda, Jun Maeda, Shinya Shimoyama, Junko Shiono, Keiichi Hirono, Kazuyuki Ikeda, Seiichi Sato, Fujito Numano, Yoshihide Mitani, Kenji Waki, Mamoru Ayusawa, Ryuji Fukazawa, Shigeto Fuse, Kenji Hamaoka, Hitoshi Kato, Tsutomu Saji, Hiroyuki Yamagishi, Masako Tomotsune, Makiko Yoshida, Manatomo Toyono, Kenji Furuno, Satoru Iwashima, Yuji Moritou, Masahiro Kamada, Atsuhito Takeda, Tetsuya Sano, Daisuke Omori, Yoshie Fukasawa, Sayaka Mii, Yuichi Nomura, Tsuneyuki Nakamura, Masahiro Ishii, Syohei Ogata, Atushi Kitagawa, Masaki Yamamoto, Kenichiro Yamamura, Hiroshi Masuda, Masahide Kaneko, Yoichi Kawamura, Akiko Komori, Hiroshi Suzuki, Kenichi Watanabe, Miyuki Hayashi, Makoto Watanabe, Kenji Kuraishi, Eiki Nishihara, Hiroshi Katayama, Kenichi Okumura, Tsutomu Takahashi, Norihisa Horita, Satoshi Matsuzaki, Noriko Motoki, Yohei Akazawa, Kentaro Aso, Kiyoshi Nagumo, Shinichi Takatuki, Eisuke Suganuma, Shinichi Matsuda, Yasunobu Hayabuchi, Shouzaburoh Doi, Takafumi Honda, Masaru Terai, Tomoyuki Miyamoto
Publikováno v:
Journal of the American Heart Association. 12
Background Coronary arterial aneurysms (CAAs) associated with Kawasaki disease (KD) significantly affect prognosis. However, the clinical course of CAAs and factors associated with CAA regression have not been well analyzed. Methods and Results The c
Autor:
Yoshihiro Onouchi, Ryuji Fukazawa, Kenichiro Yamamura, Hiroyuki Suzuki, Nobuyuki Kakimoto, Tomohiro Suenaga, Takashi Takeuchi, Hiromichi Hamada, Takafumi Honda, Kumi Yasukawa, Masaru Terai, Ryota Ebata, Kouji Higashi, Tsutomu Saji, Yasushi Kemmotsu, Shinichi Takatsuki, Kazunobu Ouchi, Fumio Kishi, Tetsushi Yoshikawa, Toshiro Nagai, Kunihiro Hamamoto, Yoshitake Sato, Akihito Honda, Hironobu Kobayashi, Junichi Sato, Shoichi Shibuta, Masakazu Miyawaki, Ko Oishi, Hironobu Yamaga, Noriyuki Aoyagi, Megumi Yoshiyama, Ritsuko Miyashita, Yuji Murata, Akihiro Fujino, Kouichi Ozaki, Tomisaku Kawasaki, Jun Abe, Mitsuru Seki, Tohru Kobayashi, Hirokazu Arakawa, Shunichi Ogawa, Toshiro Hara, Akira Hata, Toshihiro Tanaka
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0145486 (2016)
Kawasaki disease (KD; MIM#61175) is a systemic vasculitis syndrome with unknown etiology which predominantly affects infants and children. Recent findings of susceptibility genes for KD suggest possible involvement of the Ca(2+)/NFAT pathway in the p
Externí odkaz:
https://doaj.org/article/87e36abd0b434850ad3d951957d0c072
Autor:
Hiroyuki Fukushima, Fukiko Ichida, Osamu Yamada, Yasuo Ono, Shozaburo Doi, Shigetoyo Kogaki, Tsutomu Saji, Shiro Ishikawa, Takehiro Igarashi, Yoshihide Mitani, Toshio Nakanishi, Tomotaka Nakayama, Masaki Matsushima, Hirofumi Sawada
Publikováno v:
American Journal of Respiratory and Critical Care Medicine
Rationale: To detect pulmonary arterial hypertension (PAH) at any early stage is a promising approach to optimize the outcome.Objectives: To investigate the impact of school ECG-based screening on ...
Autor:
Norifumi Nakanishi, Nobuhiro Tahara, Satoshi Sakai, Yukio Ozaki, Motonori Hatta, Hiroshi Watanabe, Yoshiaki Okano, Masaru Hatano, Koichiro Yoshioka, Hiroaki Dobashi, Yasuki Kihara, Masakazu Matsushita, Tohru Minamino, Satoshi Ikeda, Masanori Funauchi, Takahisa Kondo, Keiichi Fukuda, Shigetake Sasayama, Shuji Joho, Hidehiro Yamada, Nobuhiro Tanabe, Tsutomu Saji
Publikováno v:
Current medical research and opinion. 36(6)
Objective: Macitentan, a novel dual endothelin receptor antagonist, was approved for the treatment of pulmonary arterial hypertension (PAH) in Japan. However, long-term effects in Japanese patients...
Publikováno v:
Pediatrics International. 60:232-239
Background Discussion of health-care transition (HCT) for adults with a childhood history of coronary artery lesions (CAL) after Kawasaki disease (KD) is important. A nationwide questionnaire survey was performed with support by the Japanese Society
Autor:
Hitoshi Kato, Tohru Kobayashi, Shunichi Ogawa, Kenji Hamaoka, Ryota Ebata, Tsutomu Saji, Tomio Kobayashi, Etsuko Tsuda, Hiroyuki Suzuki, Mamoru Ayusawa, Masashi Mikami, Ryuji Fukazawa, Mayumi Yashiro, Masaru Miura
Publikováno v:
Circulation Journal. 82:239-246
BACKGROUND Giant coronary aneurysm is the most severe sequela in Kawasaki disease, occurring in approximately 0.2% of patients in Japan. Regression is rare, while myocardial infarction (MI) and sudden death are relatively common. Herein, we reviewed
Publikováno v:
Endocrine Journal. 64:1173-1180
Thyroid disease is known to be associated with pulmonary arterial hypertension (PAH). We investigated the prevalence of thyroid disease in patients with idiopathic PAH (IPAH) or heritable PAH (HPAH), and the factors affecting the pathogenesis of thyr
Publikováno v:
Pediatric Cardiology and Cardiac Surgery. 33:297-311
Autor:
Rana Olguntürk, Siegrun Mebus, Ralf Geiger, Tilman Humpl, Ornella Milanesi, Maurice Beghetti, M. Fasnacht Boillat, Dursun Alehan, Damien Bonnet, I. Schulze-Neick, Tomás Pulido, V. Favero, R.J. Barst, Serdar Kula, A.M. Atz, Zhi-Cheng Jing, George B. Mallory, László Ablonczy, H. Brun, Johannes M. Douwes, Robert G. Weintraub, M. Zuk, Ch. Apitz, Eric D. Austin, Ronald W. Day, W. Kawalec, T. Jensen, J.T. Berger, L. Moll, Tsutomu Saji, Marilyne Levy, Delphine Yung, S. Mattos, P. De La Garza, Lars Søndergaard, D. Dunbar Ivy, Rolf M. F. Berger, Z.Y. Han, András Szatmári, K. Michalak, D.J. Moore, Jeffrey A. Feinstein
Publikováno v:
International Journal of Cardiology, 203, 325-330. ELSEVIER IRELAND LTD
Background The TOPP Registry has been designed to provide epidemiologic, diagnostic, clinical, and outcome data on children with pulmonary hypertension (PH) confirmed by heart catheterisation (HC). This study aims to identify important characteristic
Autor:
Keiichi Fukuda, Yasuki Kihara, Masakazu Matsushita, Tohru Minamino, Hiroaki Dobashi, Satoshi Ikeda, Shuji Joho, Nobuhiro Tahara, Hidehiro Yamada, Shigetake Sasayama, Takeshi Kimura, Norifumi Nakanishi, Masanori Funauchi, Satoshi Sakai, Hiroshi Watanabe, Yukio Ozaki, Masaru Hatano, Takahisa Kondo, Koichiro Yoshioka, Nobuhiro Tanabe, Tsutomu Saji
Publikováno v:
Circulation Journal. 80:1478-1483
BACKGROUND Macitentan is a novel, dual endothelin receptor antagonist with sustained receptor binding, used for the long-term treatment of pulmonary arterial hypertension (PAH). In the present study, we assessed the efficacy and safety of macitentan